1. 464PSafety and efficacy of trifluridine/tipiracil (FTD/TPI) in metastatic colorectal cancer (mCRC) patients according to previous treatment with regorafenib in the international phase IIIb PRECONNECT study. (23rd October 2018) Authors: Taieb, J; Falcone, A; Lonardi, S; Price, T J; Bachet, J-B; Wyrwicz, L; Ciardiello, F; Becquart, M; Mounedji, N; Van Cutsem, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. O-013Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer (mCRC): Preliminary results from the phase IIIb, international, open-label, early-access PRECONNECT study. (20th June 2018) Authors: Falcone, A; André, T; Edeline, J; François, E; Taieb, J; Phelip, J; Portales, F; Price, T; Becquart, M; Moreno Vera, S; Mounedji, N; Van Cutsem, E; Seitz, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗